businesspress24.com - CORRECTION - Bio-Rad to Report Fourth-Quarter and Full-Year 2015 Financial Results Thursday, Februar
 

CORRECTION - Bio-Rad to Report Fourth-Quarter and Full-Year 2015 Financial Results Thursday, February 25, 2016

ID: 1415536

(firmenpresse) - HERCULES, CA -- (Marketwired) -- 02/16/16 -- In the news release, "Bio-Rad to Report Fourth-Quarter and Full-Year 2015 Financial Results Thursday, February 25, 2016," issued Tuesday, February 2, 2016 by Bio-Rad Laboratories (NYSE: BIO) (NYSE: BIO.B), we are advised by the company that the first sentence of the second paragraph should read "To listen, call 855-779-9068 within the U.S. or 631-485-4862 outside the U.S., passcode: 30616978" rather than "To listen, call 631-485-4862 within the U.S. or 855-779-9068 outside the U.S., passcode: 30616978" as originally issued.



Bio-Rad Laboratories, Inc. (NYSE: BIO) (NYSE: BIO.B) develops, manufactures, and markets a broad range of innovative products and solutions for the life science research and clinical diagnostic markets. The company is renowned for its commitment to quality and customer service among university and research institutions, hospitals, public health and commercial laboratories, as well as the biotechnology, pharmaceutical, and food safety industries. Founded in 1952, Bio-Rad is based in Hercules, California, and serves more than 100,000 research and healthcare industry customers through its global network of operations. The company employs more than 7,600 people worldwide and had revenues exceeding $2.1 billion in 2014. For more information, please visit .



Christine Tsingos
Executive Vice President and Chief Financial Officer
Ron Hutton
Vice President and Treasurer
Bio-Rad Laboratories, Inc.
510-724-7000



Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Aequus Licenses Canadian Commercialization Rights to Trokendi XR(R) and Oxtellar XR(R) From Supernus
Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Cardiovascular Systems, Inc.
Bereitgestellt von Benutzer: Marketwired
Datum: 16.02.2016 - 14:00 Uhr
Sprache: Deutsch
News-ID 1415536
Anzahl Zeichen: 3119

contact information:
Contact person:
Town:

HERCULES, CA


Phone:

Kategorie:

Healthcare


Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:


Diese Pressemitteilung wurde bisher 253 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"CORRECTION - Bio-Rad to Report Fourth-Quarter and Full-Year 2015 Financial Results Thursday, February 25, 2016
"
steht unter der journalistisch-redaktionellen Verantwortung von

Bio-Rad Laboratories (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Bio-Rad Laboratories



 

Who is online

All members: 10 576
Register today: 2
Register yesterday: 0
Members online: 0
Guests online: 111


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.